Nanolive specializes in advanced live cell imaging and analysis technologies, particularly through their innovative platform known as the 3D Cell Explorer. This platform employs automated, label-free holotomography, allowing researchers to visualize and analyze living cells in three dimensions without the need for fluorescent markers. The technology is designed to facilitate high-content live cell analysis, enabling long-term monitoring of cellular health and behavior. With features such as the LIVE Cytotoxicity Assay and the LIVE T Cell Assay, Nanolive's solutions provide critical insights into cell metabolism, cytotoxicity, and immune responses, making them valuable tools for applications in biotechnology, pharmaceuticals, and cosmetics.

In addition to their imaging platforms, Nanolive integrates artificial intelligence into their analysis workflows, enhancing the capability to perform retroactive analysis on collected data. Their products, including the 3D Cell Explorer-fluo and the budget-friendly 3D Cell Explorer, cater to various research needs, from high-quality non-invasive imaging to more accessible solutions for smaller labs. By focusing on label-free techniques, Nanolive aims to revolutionize cell biology research, providing scientists with the tools necessary for in-depth cellular studies while saving time and resources in the laboratory.

Switzerland

#Nanolive: Capture dynamic, unbiased live cell data to accelerate discovery, development and therapeutics.
 
Nanolive delivers breakthrough 3D imaging solutions that accelerate research in growth industries such as drug discovery and cell therapy. Nanolive’s innovative solutions combine screening, imaging and analysis to radically advance how scientists study living cells and provide novel biological insights such as the mechanisms of cancer and neurodegenerative diseases.

NanoLive

Company Details